What does CUSIP 604749101 represent in this 13F holders report?

CUSIP 604749101 is the security identifier for MIRM - Mirum Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in Q4 2021?

81 institutional investors reported MIRM - Mirum Pharmaceuticals, Inc. - Common Stock for Q4 2021. Use the holders table for investor-level position and value details.

Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

CUSIP: 604749101

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock
Shares outstanding: 60,799,281
Total 13F shares: 22,891,220
Share change: +1,377,794
Total reported value: $365,087,000
Put/Call ratio: 83%
Price per share: $15.95
Number of holders: 81
Value change: +$18,990,411
Number of buys: 44
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 604749101?
CUSIP 604749101 identifies MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 604749101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of MIRM - Mirum Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
NEA Management Company, LLC	13F	Company	6.9%	4,187,801	$83,421,000	—	30 Sep 2021	13F
FRAZIER MANAGEMENT LLC	13F	Company	5.9%	3,566,912	$71,053,000	—	30 Sep 2021	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	5.4%	3,282,912	$65,396,000	—	30 Sep 2021	13F
Novo Holdings A/S	13F	Company	4%	2,445,147	$48,707,000	—	30 Sep 2021	13F
Rock Springs Capital Management LP	13F	Company	2.5%	1,525,623	$30,390,000	—	30 Sep 2021	13F
AXA S.A.	13F	Company	1.4%	852,172	$16,975,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	1.2%	734,647	$14,634,000	—	30 Sep 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	1.1%	647,313	$12,894,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	1%	610,565	$12,162,000	—	30 Sep 2021	13F
BVF INC/IL	13F	Company	0.72%	435,936	$8,684,000	—	30 Sep 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.6%	364,700	$7,265,000	—	30 Sep 2021	13F
MPM BioImpact LLC	13F	Company	0.51%	308,532	$6,146,000	—	30 Sep 2021	13F
Sio Capital Management, LLC	13F	Company	0.41%	248,978	$4,960,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.29%	176,673	$3,519,000	—	30 Sep 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.27%	164,402	$3,275,000	—	30 Sep 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.26%	155,275	$3,093,000	—	30 Sep 2021	13F
Point72 Asset Management, L.P.	13F	Company	0.24%	144,400	$2,876,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.22%	132,586	$2,641,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	0.21%	127,089	$2,532,000	—	30 Sep 2021	13F
Ensign Peak Advisors, Inc	13F	Company	0.21%	126,393	$2,518,000	—	30 Sep 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.15%	93,500	$1,863,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.15%	88,745	$1,768,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.14%	87,398	$1,741,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.14%	86,478	$1,723,000	—	30 Sep 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.13%	80,026	$1,594,000	—	30 Sep 2021	13F
MARSHALL WACE, LLP	13F	Company	0.11%	69,509	$1,384,000	—	30 Sep 2021	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.11%	67,020	$1,335,000	—	30 Sep 2021	13F
CHARTWELL INVESTMENT PARTNERS, LLC	13F	Company	0.11%	66,179	$1,318,000	—	30 Sep 2021	13F
Edwin Jonathan Tucker	3/4/5	Chief Medical Officer	— class O/S missing	45,838	$1,285,073	—	10 Nov 2021	3/4/5
Marshall Wace North America L.P.	13F	Company	0.09%	53,408	$1,064,000	—	30 Sep 2021	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.07%	39,708	$791,000	—	30 Sep 2021	13F
Invesco Ltd.	13F	Company	0.06%	39,438	$786,000	—	30 Sep 2021	13F
ALPS ADVISORS INC	13F	Company	0.06%	37,401	$745,000	—	30 Sep 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	35,300	$703,000	—	30 Sep 2021	13F
ExodusPoint Capital Management, LP	13F	Company	0.04%	27,253	$543,000	—	30 Sep 2021	13F
Mesirow Financial Investment Management, Inc.	13F	Company	0.04%	25,795	$514,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.04%	23,844	$475,000	—	30 Sep 2021	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.04%	23,748	$473,000	—	30 Sep 2021	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.04%	22,410	$446,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.03%	19,988	$399,000	—	30 Sep 2021	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.03%	19,865	$396,000	—	30 Sep 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	16,700	$333,000	—	30 Sep 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.03%	15,676	$312,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	14,696	$293,000	—	30 Sep 2021	13F
VIRTUS ADVISERS, LLC	13F	Company	0.02%	11,984	$239,000	—	30 Sep 2021	13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	13F	Company	0.02%	11,973	$239,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.02%	11,016	$220,000	—	30 Sep 2021	13F
HRT FINANCIAL LP	13F	Company	0.02%	10,792	$214,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.02%	11,020	$199,000	—	30 Sep 2021	13F
STRS OHIO	13F	Company	0.02%	9,600	$191,000	—	30 Sep 2021	13F

Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q4 2021

As of 31 Dec 2021, Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,891,220 shares. The largest 10 holders included NEA Management Company, LLC, FRAZIER MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Novo Holdings A/S, Rock Springs Capital Management LP, AXA S.A., VANGUARD GROUP INC, BlackRock Inc., FRANKLIN RESOURCES INC, and BVF INC/IL. This page lists 81 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.